This metabolic brain boost revives memory in Alzheimer’s mice
An experimental cancer drug that helps the brain turn glucose into energy was able to reverse memory loss in a mouse model of Alzheimer’s disease.
Alzheimer's research
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s
Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.
When a brain injury impairs memory, a pulse of electricity may help
A severe traumatic brain injury can make it hard to remember recent events or conversations. But a form of brain stimulation appears to ease this memory deficit.
Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
An Alzheimer's drug is on the way, but getting it may still be tough. Here's why
The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.
Scientists zap sleeping humans' brains with electricity to improve their memory
Scientists have shown that deep brain stimulation during sleep can help people retain new information. The approach could help people with memory problems related to disorders like Alzheimer's.
FDA approves Alzheimer's drug that appears to modestly slow disease
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.
Study: Alzheimer's drug shows modest success slowing declines in memory, thinking
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
What causes Alzheimer's? Study puts leading theory to 'ultimate test'
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.